Data gathered: April 18
Alternative Data for Jazz Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 60 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 90,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | 33 | Sign up | Sign up | Sign up |
| Patents | 88 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 12 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 4,031 | Sign up | Sign up | Sign up |
| Twitter Followers | 3,555 | Sign up | Sign up | Sign up |
| Twitter Mentions | 20 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 45 | Sign up | Sign up | Sign up |
| Linkedin Employees | 3,417 | Sign up | Sign up | Sign up |
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally.
| Price | $102.78 |
| Target Price | Sign up |
| Volume | 995,230 |
| Market Cap | $6.24B |
| Year Range | $100.5 - $144.17 |
| Dividend Yield | 0% |
| PE Ratio | 11.73 |
| Analyst Rating | 88% buy |
| Industry | Biotechnology |
In the news
 |
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Bank of Montreal CanApril 17 - ETF Daily News |
 |
JAZZ vs. ARGX: Which Stock Is the Better Value Option?April 17 - Yahoo |
|
Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-TermApril 16 - Yahoo |
|
Is Jazz Pharmaceuticals a Top Cannabis Investment for 2025?April 16 - Yahoo |
|
Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs PeersApril 16 - Yahoo |
|
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Wells Fargo & Company MNApril 16 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 1.05B | 483M | 571M | 215M | 418M | 6.610 |
| Q2 '24 | 1.02B | 494M | 531M | 169M | 355M | 5.300 |
| Q1 '24 | 900M | 507M | 393M | -15M | 222M | 2.680 |
| Q4 '23 | 988M | 548M | 440M | 94M | 275M | 5.020 |
| Q3 '23 | 971M | 463M | 508M | 147M | 327M | 4.840 |
Insider Transactions View All
| COZADD BRUCE C filed to sell 440,307 shares at $123.8. April 3 '25 |
| Carr Patricia filed to sell 7,012 shares at $137.8. March 11 '25 |
| Iannone Robert filed to sell 79,621 shares at $138.4. March 12 '25 |
| Iannone Robert filed to sell 82,024 shares at $140. March 7 '25 |
| Iannone Robert filed to sell 83,572 shares at $138.2. March 7 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Daniel S. Goldman Democrat |
Aug 13, 23 | Sell | $15K - $50K |
| Rohit Khanna Democrat |
Jun 12, 23 | Sell | $1K - $15K |
Read more about Jazz Pharmaceuticals (JAZZ) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Jazz Pharmaceuticals?
The Market Cap of Jazz Pharmaceuticals is $6.24B.
What is Jazz Pharmaceuticals' PE Ratio?
As of today, Jazz Pharmaceuticals' PE (Price to Earnings) ratio is 11.73.
What is the current stock price of Jazz Pharmaceuticals?
Currently, the price of one share of Jazz Pharmaceuticals stock is $102.78.
How can I analyze the JAZZ stock price chart for investment decisions?
The JAZZ stock price chart above provides a comprehensive visual representation of Jazz Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Jazz Pharmaceuticals shares. Our platform offers an up-to-date JAZZ stock price chart, along with technical data analysis and alternative data insights.
Does JAZZ offer dividends to its shareholders?
As of our latest update, Jazz Pharmaceuticals (JAZZ) does not offer dividends to its shareholders. Investors interested in Jazz Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Jazz Pharmaceuticals?
Some of the similar stocks of Jazz Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.